Effects of addition of Armodafinil on the tolerability and efficacy for cognition of atypical antipsychotic drugs in patients with schizophrenia or schizoaffective disorder
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Armodafinil (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 01 Aug 2011 Results published in the Schizophrenia Research.
- 02 Mar 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.